Endometriosis Treatment Market to Surge to US$ 3.1 Billion by 2034: Innovations in Surgical Procedures and Fertility-Preserving Medications Drive Market Growth | TMR
Comunicato Precedente
Comunicato Successivo
Hormone therapies such as GnRH agonists and antagonists, aromatase inhibitors, and other hormonal medicines, are crucial in controlling endometriosis-related pain. Newer medications, such as GnRH antagonists like Elagolix and Letrozole, have showed promise, especially in terms of pain relief and fertility outcomes.
Despite the range of treatment choices, the market faces obstacles in providing effective long-term solutions that do not jeopardize fertility. Drugs such as Elagolix, which was licensed by the FDA in 2018, have considerable potential but require additional investigation, particularly in terms of its usage in pre-treatment prior to in vitro fertilization. Elagolix's ongoing clinical research (NCT04173169) is expected to provide useful insights once completed in September 2024.
Request a PDF Sample of this Report Now
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20834
The market is also looking into selective estrogen receptor modulators (SERMs), such as SR-16234, which show promise due to their unique receptor action but require further clinical validation. Furthermore, established treatments like Danazol are still being contested due to their negative effects, whereas medications like Gestrinone are less often used and unavailable in areas such as the United States.
Key Takeaways from the Market Study
Key Drivers and Trends
Endometriosis Treatment Market Report Scope:
Unlock Growth Potential in Your Industry Download PDF Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20834
Key Regions Profiled
Competitive Landscape
Players in the endometriosis treatment landscape are seeking fast track approvals for their products from regulatory authorities. Given the highly complex nature of this treatment, providers have to comply with stringent guidelines before they make the said approach available to end users. Some prominent endometriosis treatment providers are given below:
Key Developments
Segments Profiled
Treatment Type
Drug Class
Distribution Channel
Region
Purchase the Report for Market-Driven Insights: https://www.transparencymarketresearch.com/checkout.php?rep_id=20834<ype=S
More Trending Report by Transparency Market Research:
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
Follow Us: LinkedIn| Twitter| Blog | YouTube
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/endometriosis-treatment-market-to-surge-to-us-3-1-billion-by-2034-innovations-in-surgical-procedures-and-fertility-preserving-medications-drive-market-growth--tmr-302207553.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
